On September 7, 2024, Dr. Veerapol Khemarangsan (2nd from left), Chief Executive Officer; Mr. Pipat Pisanuwongruk (1st from right), Chief Accounting and Financial Officer of MEDEZE Treasury PTE. LTD.; Ms. Danita Phithaknetikun (3rd from right), Chief Business Development Officer; Assoc. Prof. Dr. Paiboon Sereewiwattana (2nd from right), Financial Planning Advisor of MEDEZE Group Public Company Limited (MEDEZE), a leading provider of stem cell analysis, isolation, cultivation, and storage services, as well as immune cell (NK Cell) potential evaluation, were joined by Mr. Pawarit Wesssupharat (1st from left), Deputy Director of Investment Banking at Yuanta Securities (Thailand) Co., Ltd., acting as the financial advisor and lead manager for the offering of additional common shares.
Together, they presented detailed information to investors at the Retail Investor Roadshow, providing insights into the company’s IPO offering of 268 million shares in preparation for MEDEZE’s listing on the Stock Exchange of Thailand (SET). The event was held at the Four Seasons Hotel Bangkok at Chao Phraya River.
IR Press Releases